SCHEMBL3434040

SCHEMBL3434040

CCCS(=O)(=O)CCCS(=O)(=O)Nc1ccc(F)c(C(=O)Nc2cnc3[nH]ccc3c2)c1C

nearest known ligand 0.87

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BRAF P15056 20/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1773272 0.93 BRAF (1.00) BRAF
SCHEMBL3429848 0.92 BRAF (0.87) BRAF
SCHEMBL3431914 0.88 BRAF (0.87) BRAF
SCHEMBL3430445 0.87 BRAF (0.87) BRAF
SCHEMBL1772009 0.85 BRAF (1.00) BRAF
SCHEMBL1772569 0.85 BRAF (1.00) BRAF
SCHEMBL1771981 0.84 BRAF (0.79) BRAF
SCHEMBL1772408 0.84 BRAF (0.84) BRAF
SCHEMBL1772027 0.81 BRAF (1.00) BRAF
SCHEMBL1772294 0.81 BRAF (1.00) BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265608-A2 RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF Array Biopharma, Inc. (US) 2010-12-29 EP disclosed
WO-2009111278-A2 RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF ARRAY BIOPHARMA INC. (US) 2009-09-11 WO disclosed